OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use

The OnabotulinumtoxinA in Chronic Migraine Adis Drug Q&A video abstract, script and image slide deck provide a brief overview of the mechanism of action of onabotulinumtoxinA in chronic migraine, the administration regimen and the key efficacy and tolerability outcomes from clinical trials and real world studies.

The video abstract, script and slide deck, which have been peer reviewed and were uploaded to Figshare after the OnabotulinumtoxinA in Chronic Migraine Adis Drug Q&A was published, are sponsored by AbbVie.

The video abstract can be found here.

© Springer Nature Switzerland AG 2021